
Home > For Patients
Information for Patients
OPK Biotech's information regarding Hemopure is intended as an information source for healthcare professionals. It is not the function of OPK Biotech to substitute for the role of the clinician, or to enable members of the public themselves to take medical procedure decisions or actions for themselves, but to support the clinician in providing individuals access to information and understanding. The information and understanding available on the OPK Biotech site needs to be applied by the clinician to make a diagnosis and/or to propose treatment. Members of the public are therefore urged to consult with a health professional for answers to any health-related questions.
Questions & Answers for patients
When can Hemopure be used?
Hemopure was approved in 2001 by the MCC for the treatment of adult surgical patients who are acutely anaemic. Hemopure is indicated for the purpose of eliminating, delaying or reducing the need for allogenic red blood cells.
How will I know when I need Hemopure?
Your doctor will know when and if you will ever require Hemopure. Ask him when you are discussing your treatment plan and options.
Can any blood type use Hemopure?
Yes, Hemopure does not require blood typing.
What if I am pregnant? Can I use Hemopure then?
The safety of Hemopure in pregnant or nursing women has not been
determined, therefore, we recommend that you tell your doctor if you might be pregnant or if you are nursing your baby.
Hemopure has been approved by the MCC for the treatment of adult surgical patients who are acutely anaemic. Hemopure is indicated for the purpose of eliminating, delaying or reducing the need for allogenic red blood cells.
086 043 6678
Laboratory
Interference Guide
Practical Information for monitoring patients after Hemopure administration. Covers haemotology, clinical monitoring, serum chemistry, coagulation and urinalysis. Learn more
Notice:
December 2009
Hemopure is currently unavailable. Please check back for updates.